Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Vascular Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03850730
What this trial is testing

Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia

Who this might be right for
Hereditary Hemorrhagic TelangiectasiaEpistaxis
Cure HHT 30
Not applicableUnknownNCT03306836
What this trial is testing

Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 2

Who this might be right for
Cerebral AneurysmArteriovenous Malformations
Beijing Tiantan Hospital 408
Large-scale testing (Phase 3)Looking for participantsNCT07285005
What this trial is testing

Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome

Who this might be right for
Venous MalformationsLymphatic MalformationsKlippel-Trenaunay Syndrome+1 more
Kaken Pharmaceutical 150
Not applicableStudy completedNCT02144532
What this trial is testing

Wearing a Compression Garment for Patients With Hypermobility Type of Ehlers-Danlos Syndrome

Who this might be right for
Ehlers-Danlos Syndrome Hypermobility Type
Hospices Civils de Lyon 48
Very early researchEnded earlyNCT03001349
What this trial is testing

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

Who this might be right for
MeningiomaMetastatic Well Differentiated Neuroendocrine NeoplasmMultiple Endocrine Neoplasia Type 1+3 more
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)WithdrawnNCT02301949
What this trial is testing

Retreatment and Its Efficiency of Thalidomide for Vascular Malformation Patients With Failure of First Course Treatment

Who this might be right for
Gastrointestinal Bleeding of Unknown OriginGastrointestinal Vascular MalformationThalidomide Efficiency
Zhizheng Ge
Not applicableLooking for participantsNCT06768008
What this trial is testing

An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease

Who this might be right for
Congenital Heart DiseaseCoarctation of AortaAortic Stenosis+9 more
Beijing Anzhen Hospital 10,000
Not applicableLooking for participantsNCT06807099
What this trial is testing

WRAP North America

Who this might be right for
Venous StenosisVenous Occlusion
Merit Medical Systems, Inc. 250
Not applicableStudy completedNCT03888014
What this trial is testing

Intraoperative Fluorescence With Augmented Reality

Who this might be right for
Vascular; Lesion, Central Nervous SystemBrain TumorCerebral Aneurysm+1 more
Cedars-Sinai Medical Center 7
Not applicableUnknownNCT03262987
What this trial is testing

Color Doppler U/S vs MSCT Venography in May-Thurner Syndrome

Who this might be right for
May-Thurner Syndrome
Assiut University 25
Not applicableLooking for participantsNCT07220226
What this trial is testing

Venous Compression in Fontan

Who this might be right for
Single-ventricleFontan Circulation
University of Texas Southwestern Medical Center 20
Post-approval studies (Phase 4)Ended earlyNCT03051698
What this trial is testing

C1-inhibitor in Allergic ASThma Patients

Who this might be right for
Asthma
T. van der Poll 37
Not applicableNot Yet RecruitingNCT07075887
What this trial is testing

Optic Nerve Head Evaluation Through Multimodal Blood Flow Analysis: a Prospective Observational, Multi-center Study

Who this might be right for
Neuro-OphthalmologyOptic NeuropathiesOptic Atrophy, Hereditary, Leber+3 more
Barboni 70
Not applicableLooking for participantsNCT07382128
What this trial is testing

Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes

Who this might be right for
HCM - Hypertrophic CardiomyopathyAnderson Fabry DiseaseCardiac Magnetic Resonance Imaging+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 250
Large-scale testing (Phase 3)Study completedNCT02384122
What this trial is testing

Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias

Who this might be right for
AngiodysplasiaVascular MalformationsGastrointestinal Hemorrhage+1 more
Radboud University Medical Center 62
Not applicableLooking for participantsNCT07543731
What this trial is testing

A Real-World Study of Long-Term Adherence and Persistence to Inclisiran, Evolocumab, and Alirocumab

Who this might be right for
Cardiovascular DiseasesAtherosclerotic Cardiovascular DiseaseHypercholesterolemia, Familial
Novartis Pharmaceuticals 5,995
Large-scale testing (Phase 3)Ended earlyNCT04378075
What this trial is testing

Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy

Who this might be right for
Mitochondrial DiseasesDrug Resistant EpilepsyLeigh Disease+5 more
PTC Therapeutics 68
Not applicableWithdrawnNCT06554730
What this trial is testing

MSD Belzutifan PAS

Who this might be right for
Von Hippel Lindau Disease
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Looking for participantsNCT07167329
What this trial is testing

Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial

Who this might be right for
Von Hippel LindauVon Hippel Lindau DiseaseVon Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma+5 more
José Claudio Casali da Rocha 100
Early research (Phase 1)Not Yet RecruitingNCT07075757
What this trial is testing

In Situ Injection of Anti-angiogenics in Patients With Brain Arteriovenous Malformations Not Eligible for Exclusion Treatment

Who this might be right for
Brain Arteriovenous Malformations
Assistance Publique - Hôpitaux de Paris 20
Next Page